Proposed Data Collections Submitted for Public Comment and Recommendations, 60471-60472 [2014-23865]

Download as PDF 60471 Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60-Day–14–14BAA] Proposed Data Collections Submitted for Public Comment and Recommendations The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. To request more information on the below proposed project or to obtain a copy of the information collection plan and instruments, call 404–639–7570 or send comments to Leroy A. Richardson, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments submitted in response to this notice will be summarized and/or included in the request for Office of Management and Budget (OMB) approval. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Written comments should be received within 60 days of this notice. (the ‘‘VP Program’’) to coordinate and integrate efforts in high-risk communities involving CDC, national organizations, and community partners. Through the VP Program, six national organizations received cooperative agreements to assist a total of 18 communities with planning, implementing, and evaluating community-based diabetes control programs. Each VP awardee is required to use the community change framework to guide their work with three communities. CDC proposes to collect information to learn more about how the community change approach is working in communities that are significantly impacted by factors that influence the disproportionate burden of diabetes in vulnerable populations, such as low income, limited education, limited access to health care, and a physical environment that does not promote health. Semi-structured telephone interviews will be conducted with key personnel associated with each national organization (awardee) and each community site. One project coordinator and one consultant at each of the six VP grantee organizations (n=12) will be asked to participate in an interview of 1.5 hours in length. In addition, an interview of approximately 1.5 hours will be conducted with one community partner or one coalition member at each community site (n=18) and one site coordinator at each community site (n=18) over a two-month period. The interviews will allow CDC to explore capacity building and support strategies used by the awardees to facilitate community change, and provide insight into the facilitators and barriers experienced by the program stakeholders in addressing diabetes in their communities. OMB approval is requested for one year. Data collection, management, and analysis will be conducted by a contractor working on behalf of CDC. Participation in the interviews is voluntary and there are no costs to respondents other than their time. Proposed Project A Comprehensive Assessment of the National Program to Eliminate Diabetes Related Health Disparities in Vulnerable Populations—New—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Diabetes affects over 29 million people in the United States, is the sixth leading cause of death in the country, and can cause serious health complications including heart disease, blindness, kidney failure, and lowerextremity amputations. The overall prevalence of diabetes in the U.S. is > 9%, however, higher rates of type 2 diabetes and its complications exist in particular subgroups of the population. These subgroups include adults ages 60 years and older, racial and ethnic minority groups (e.g., African Americans, Hispanic/Latino Americans, American Indians, Native Hawaiians and other Pacific Islanders, and some Asian Americans), people with low socioeconomic status (SES), and rural populations. Population subgroups that are not well integrated into the health care system because of ethnic, cultural, economic, or geographic characteristics, and that may not receive adequate health care, are considered vulnerable populations. In an effort to reduce diabetes-related disparities, CDC’s Division of Diabetes Translation (DDT) aims to concentrate efforts where the greatest impact can be achieved for populations with the greatest burden or risk of diabetes. DDT established the National Program to Eliminate Diabetes Related Health Disparities in Vulnerable Populations asabaliauskas on DSK5VPTVN1PROD with NOTICES ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden hours Type of respondent Form name Grantee (Staff Designee and Consultant). Community Partner/Coalition Member. Grantee Interview Guide .................. 12 1 1.5 18 Community Partner/Coalition Member Interview Guide. 18 1 1.5 27 VerDate Sep<11>2014 17:15 Oct 06, 2014 Jkt 235001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\07OCN1.SGM 07OCN1 60472 Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of responses per respondent Number of respondents Average burden per response (in hours) Total burden hours Type of respondent Form name Site Coordinator ................................ Site Coordinator Interview Guide ..... 18 1 1.5 27 Total ........................................... ........................................................... ........................ ........................ ........................ 72 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention [FR Doc. 2014–23865 Filed 10–6–14; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES The meeting announced below concerns Workers’ Compensation Surveillance, PAR14–227, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Centers for Disease Control and Prevention asabaliauskas on DSK5VPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the charter for the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through September 18, 2016. For information, contact Catherine Ramadei, Acting Designated Federal Officer, Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road NE., Mailstop K48, Atlanta, Georgia 30333, telephone (770) 488– 4796 or fax (404) 248–4152. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Time and Date: 11:00 a.m.–7:00 p.m., November 5, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Workers’ Compensation Surveillance, PAR14–227, initial review.’’ Contact Person for More Information: Donald Blackman, Ph.D., Scientific Review Officer, CDC, 2400 Century Center Parkway NE., 4th Floor, Room 4204, Mailstop E–74, Atlanta, Georgia 30345, Telephone: (404) 498–6185, DYB7@CDC.GOV . The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–23854 Filed 10–6–14; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2014–23858 Filed 10–6–14; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:15 Oct 06, 2014 Jkt 235001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 8:15 a.m.–4:30 p.m., Pacific Daylight Time, November 6, 2014. Public Comment Time and Date: 4:30 p.m.–5:30 p.m., Pacific Daylight Time, November 6, 2014. Place: Hilton Garden Inn Los Angeles/ Redondo Beach, 2410 Marine Avenue, Redondo Beach, CA 90278, Phone: 310– 727–9999; Fax: 310–727–9998. Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1– 866–659–0537 with a pass code of 9933701. Live Meeting Connection: https:// www.livemeeting.com/cc/cdc/join?id= ZN5GQZ&role=attend&pw=ABRWH; Meeting ID: ZN5GQZ; Entry Code: ABRWH. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 100 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific E:\FR\FM\07OCN1.SGM 07OCN1

Agencies

[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Pages 60471-60472]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23865]



[[Page 60471]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-14-14BAA]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC), as part of 
its continuing effort to reduce public burden, invites the general 
public and other Federal agencies to take this opportunity to comment 
on proposed and/or continuing information collections, as required by 
the Paperwork Reduction Act of 1995. To request more information on the 
below proposed project or to obtain a copy of the information 
collection plan and instruments, call 404-639-7570 or send comments to 
Leroy A. Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or 
send an email to omb@cdc.gov.
    Comments submitted in response to this notice will be summarized 
and/or included in the request for Office of Management and Budget 
(OMB) approval. Comments are invited on: (a) Whether the proposed 
collection of information is necessary for the proper performance of 
the functions of the agency, including whether the information shall 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden of the proposed collection of information; (c) ways to 
enhance the quality, utility, and clarity of the information to be 
collected; (d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques or other forms of information technology; and (e) 
estimates of capital or start-up costs and costs of operation, 
maintenance, and purchase of services to provide information. Burden 
means the total time, effort, or financial resources expended by 
persons to generate, maintain, retain, disclose or provide information 
to or for a Federal agency. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information. Written comments should be received within 60 
days of this notice.

Proposed Project

    A Comprehensive Assessment of the National Program to Eliminate 
Diabetes Related Health Disparities in Vulnerable Populations--New--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Diabetes affects over 29 million people in the United States, is 
the sixth leading cause of death in the country, and can cause serious 
health complications including heart disease, blindness, kidney 
failure, and lower-extremity amputations. The overall prevalence of 
diabetes in the U.S. is > 9%, however, higher rates of type 2 diabetes 
and its complications exist in particular subgroups of the population. 
These subgroups include adults ages 60 years and older, racial and 
ethnic minority groups (e.g., African Americans, Hispanic/Latino 
Americans, American Indians, Native Hawaiians and other Pacific 
Islanders, and some Asian Americans), people with low socioeconomic 
status (SES), and rural populations. Population subgroups that are not 
well integrated into the health care system because of ethnic, 
cultural, economic, or geographic characteristics, and that may not 
receive adequate health care, are considered vulnerable populations.
    In an effort to reduce diabetes-related disparities, CDC's Division 
of Diabetes Translation (DDT) aims to concentrate efforts where the 
greatest impact can be achieved for populations with the greatest 
burden or risk of diabetes. DDT established the National Program to 
Eliminate Diabetes Related Health Disparities in Vulnerable Populations 
(the ``VP Program'') to coordinate and integrate efforts in high-risk 
communities involving CDC, national organizations, and community 
partners. Through the VP Program, six national organizations received 
cooperative agreements to assist a total of 18 communities with 
planning, implementing, and evaluating community-based diabetes control 
programs. Each VP awardee is required to use the community change 
framework to guide their work with three communities.
    CDC proposes to collect information to learn more about how the 
community change approach is working in communities that are 
significantly impacted by factors that influence the disproportionate 
burden of diabetes in vulnerable populations, such as low income, 
limited education, limited access to health care, and a physical 
environment that does not promote health.
    Semi-structured telephone interviews will be conducted with key 
personnel associated with each national organization (awardee) and each 
community site. One project coordinator and one consultant at each of 
the six VP grantee organizations (n=12) will be asked to participate in 
an interview of 1.5 hours in length. In addition, an interview of 
approximately 1.5 hours will be conducted with one community partner or 
one coalition member at each community site (n=18) and one site 
coordinator at each community site (n=18) over a two-month period. The 
interviews will allow CDC to explore capacity building and support 
strategies used by the awardees to facilitate community change, and 
provide insight into the facilitators and barriers experienced by the 
program stakeholders in addressing diabetes in their communities.
    OMB approval is requested for one year. Data collection, 
management, and analysis will be conducted by a contractor working on 
behalf of CDC. Participation in the interviews is voluntary and there 
are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of respondent            Form name       respondents    responses per   response (in        hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Grantee (Staff Designee and     Grantee                       12               1             1.5              18
 Consultant).                    Interview Guide.
Community Partner/Coalition     Community                     18               1             1.5              27
 Member.                         Partner/
                                 Coalition
                                 Member
                                 Interview Guide.

[[Page 60472]]

 
Site Coordinator..............  Site Coordinator              18               1             1.5              27
                                 Interview Guide.
                               ---------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............              72
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-23865 Filed 10-6-14; 8:45 am]
BILLING CODE 4163-18-P